Cite
HARVARD Citation
Liu, Y. et al. (2017). CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3‐CD44‐IGF2 signalling. Journal of cellular and molecular medicine. 21 (9), pp. 1979-1988. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liu, Y. et al. (2017). CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3‐CD44‐IGF2 signalling. Journal of cellular and molecular medicine. 21 (9), pp. 1979-1988. [Online].